Form 4: 10x Genomics CEO Serge Saxonov Sells Shares

10x Genomics CEO Serge Saxonov sold 4,660 shares of Class A Common Stock at an average price of $43.9959 on March 4, 2024.

Summary

• On March 4, 2024, Serge Saxonov, the CEO of 10x Genomics, sold 4,660 shares of Class A Common Stock.
• The sale was executed at a weighted average price of $43.9959 per share, with individual trades ranging from $43.9600 to $44.0401.
• Following the transaction, Saxonov directly owns 842,900 shares.
• Saxonov also indirectly owns shares through several trusts, including the Andromeda Trust (27 shares), the Sirius Trust (870 shares), the Y/S Descendants' Trust (183,350 shares), and the Y/S Pot Trust (16,320 shares).

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine disclosure of an insider stock sale. The size of the sale is relatively small compared to Saxonov's total holdings.

Industry Context

This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a change in the company's outlook or performance. Investors often monitor insider transactions for signals about management's confidence in the company's future prospects.

Stakeholder Impact

• The sale of shares by the CEO could have a minor psychological impact on shareholders, but the overall impact is likely to be minimal given the size of the transaction relative to the CEO's total holdings and the company's market capitalization.

Key Dates